ImaginAb Enrolls First Patient in Phase II Clinical Trial at a World-Leading Cancer Center in Los Angeles County

LOS ANGELES, CA, May 16, 2019 – ImaginAb Inc., a clinical stage immuno-oncology imaging company, announces it has enrolled its first patient for the Phase II clinical trial of its lead product, CD8 tracer 89Zr-Df-IAB22M2C, at City of Hope in Los Angeles County. City of Hope is a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases based in Duarte, California, where ImaginAb co-founder Anna Wu, Ph.D., is currently Chair of Molecular Imaging and Therapy.

Read more….

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH